application): The stimulus for this Program Project Grant (PPG) is the recent remarkable identification of >10 different pathogenic tau gene mutations in >20 distinct kindreds with autosomal dominant familial Frontotemporal Dementia (FTD) and Parkinsonism linked to chromosome 17 (FTDP-17). These landmark discoveries create bold new opportunities to elucidate cellular and molecular mechanisms of neurodegenerative diseases (tauopathies) characterized by prominent tau pathologies as well as the role of these pathologies in the progressive neuropsychiatric decline, brain degeneration and death of FTDP-17 patients, often before age 60. Significantly, insight into mechanisms of disease in FTDP-17 will clarify how brain degeneration occurs in more common tauopathies, including Alzheimer's disease (AD). Thus, this PPG capitalizes on the provocative discoveries of pathogenic tau gene mutations by pursuing multidisciplinary studies of the pathobiology of FTDP-17 and related tauopathies. The research interests of the investigators in this PPG converged prior to the discovery of the FTDP-17 mutations, and they now will work synergistically to develop an understanding of how abnormal tau gene regulation and tau protein dysfunction lead to the death of affected cells and diverse FTDP-17 phenotypes as well as seemingly sporadic FTDs. The goals of 4 projects in this PPG are to: 1. develop an understanding of the spectrum of clinical phenotypes that define sporadic FTDs, 2. identify new tau gene mutations and other abnormalities in tau gene regulation that cause FTDP-17 syndromes and sporadic FTDs, 3. elucidate how aberrant tau genes result in dysfunction (losses of normal functions, gains of toxic properties) of tau proteins and diverse tauopathies, 4. create transgenic mouse models of tauopathies and test hypotheses on mechanisms whereby tau pathologies lead to brain degeneration in tauopathies. Insights gained by this sophisticated, multidisciplinary team into the role of tau pathologies in mechanisms of brain degeneration in sporadic and familial tauopathies will hasten efforts to design better and more therapeutic interventions for these disorders, including AD, the most common tauopathy.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Program Projects (P01)
Project #
1P01AG017586-01
Application #
6033534
Study Section
National Institute on Aging Initial Review Group (NIA)
Program Officer
Snyder, D Stephen
Project Start
2000-03-15
Project End
2005-02-28
Budget Start
2000-03-15
Budget End
2001-02-28
Support Year
1
Fiscal Year
2000
Total Cost
$1,176,553
Indirect Cost
Name
University of Pennsylvania
Department
Pathology
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Irwin, David J; Xie, Sharon X; Coughlin, David et al. (2018) CSF tau and ?-amyloid predict cerebral synucleinopathy in autopsied Lewy body disorders. Neurology 90:e1038-e1046
Ferraro, Pilar M; Jester, Charles; Olm, Christopher A et al. (2018) Perfusion alterations converge with patterns of pathological spread in transactive response DNA-binding protein 43 proteinopathies. Neurobiol Aging 68:85-92
Massimo, Lauren; Xie, Sharon X; Rennert, Lior et al. (2018) Occupational attainment influences longitudinal decline in behavioral variant frontotemporal degeneration. Brain Imaging Behav :
Spiller, Krista J; Restrepo, Clark R; Khan, Tahiyana et al. (2018) Microglia-mediated recovery from ALS-relevant motor neuron degeneration in a mouse model of TDP-43 proteinopathy. Nat Neurosci 21:329-340
Rey, Nolwen L; George, Sonia; Steiner, Jennifer A et al. (2018) Spread of aggregates after olfactory bulb injection of ?-synuclein fibrils is associated with early neuronal loss and is reduced long term. Acta Neuropathol 135:65-83
Irwin, David J; McMillan, Corey T; Xie, Sharon X et al. (2018) Asymmetry of post-mortem neuropathology in behavioural-variant frontotemporal dementia. Brain 141:288-301
Lewczuk, Piotr; Riederer, Peter; O'Bryant, Sid E et al. (2018) Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry. World J Biol Psychiatry 19:244-328
Phillips, Jeffrey S; Da Re, Fulvio; Dratch, Laynie et al. (2018) Neocortical origin and progression of gray matter atrophy in nonamnestic Alzheimer's disease. Neurobiol Aging 63:75-87
Kassubek, Jan; Müller, Hans-Peter; Del Tredici, Kelly et al. (2018) Longitudinal Diffusion Tensor Imaging Resembles Patterns of Pathology Progression in Behavioral Variant Frontotemporal Dementia (bvFTD). Front Aging Neurosci 10:47
Cousins, Katheryn A Q; Ash, Sharon; Grossman, Murray (2018) Production of verbs related to body movement in amyotrophic lateral sclerosis (ALS) and Parkinson's Disease (PD). Cortex 100:127-139

Showing the most recent 10 out of 593 publications